ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,543Medicare Part D Prescriptions Filled, Including Refills

Rank: 374 out of 1121

$390K Total Retail Price of All Prescriptions

Rank: 541 out of 1121

475 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 475 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 475 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 8,655 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
SIMVASTATIN 688 639 1 1
LISINOPRIL 458 430 2 4
OMEPRAZOLE 337 285 3 6
FUROSEMIDE 334 286 4 7
LEVOTHYROXINE SODIUM 334 308 4 2
AMLODIPINE BESYLATE 287 265 6 5
HYDROCODONE-ACETAMINOPHEN 256 214 S3 7 3
METOPROLOL TARTRATE 229 219 8 9
LOSARTAN POTASSIUM 182 179 9 17
GABAPENTIN 179 143 10 13
CARVEDILOL 165 158 11 20
METOPROLOL SUCCINATE 157 144 12 23
METFORMIN HCL 154 142 13 8
NAMENDA 154 154 13 53
ACETAMINOPHEN-CODEINE 143 130 S3 15 161
ATORVASTATIN CALCIUM 134 120 16 15
ISOSORBIDE MONONITRATE ER 124 124 17 62
TRAMADOL HCL 123 98 18 25
WARFARIN SODIUM 121 120 19 11
ATENOLOL 118 103 20 16
TRIAMTERENE-HCTZ 102 99 21 38
POLYETHYLENE GLYCOL 3350 101 97 22 70
SERTRALINE HCL 98 89 23 21
CLONIDINE HCL 98 80 23 39
DONEPEZIL HCL 98 98 23 35
GLIMEPIRIDE 97 83 26 34
RANITIDINE HCL 95 90 27 33
CITALOPRAM HBR 91 91 28 18
MELOXICAM 88 87 29 22
DOXAZOSIN MESYLATE 87 84 30 93
DIGOXIN 83 83 31 59
SPIRONOLACTONE 83 79 31 54
ALLOPURINOL 81 79 33 30
GLYBURIDE 80 72 R 34 51
PRAVASTATIN SODIUM 79 75 35 14
HYDRALAZINE HCL 73 73 36 66
CLOPIDOGREL 71 70 37 27
TRAZODONE HCL 60 60 38 40
PLAVIX 59 59 39 42
LANTUS SOLOSTAR 57 45 40 109
ZOLPIDEM TARTRATE 57 46 40 19
POTASSIUM CHLORIDE 54 36 42 12
FLUTICASONE PROPIONATE 53 50 43 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 27, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.